During the past decade, Turkey Creek Medical Center conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 9 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Turkey Creek Medical Center" #1 sponsor was "Abbott Medical Devices" with 5 trials, followed by "Atrium Medical Corporation" with 2 trials sponsored, "American Regent, Inc." with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Angel Medical Systems" with 1 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Turkey Creek Medical Center" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Abiomed Inc." with 1 trials as a collaborator, "Chiesi Farmaceutici S.p.A." with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Mayo Clinic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Turkey Creek Medical Center" are "Atrial Fibrillation" (3 trials), "Stroke" (3 trials), "Acute Coronary Syndrome" (2 trials), "Atherosclerotic Cardiovascular Disease" (2 trials) and "Carotid Artery Stenosis" (2 trials). Many other conditions were trialed in "Turkey Creek Medical Center" in a lesser frequency.

Most popular intervention types in "Turkey Creek Medical Center" are "Device" (23 trials), "Drug" (7 trials), "Other" (3 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Absorb BVS" (2 trials), "Placebo" (2 trials), "2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent)" (1 trials), "AMPLATZER™ PFO Occluder" (1 trials) and "Antiplatelet Drug" (1 trials). Other intervention names were less common.

The vast majority of trials in "Turkey Creek Medical Center" are 32 trials for "All" genders.

Currently, there are NaN active trials in "Turkey Creek Medical Center". undefined are not yet recruiting, 8 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Turkey Creek Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Turkey Creek Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 19 trials that are defined as “Not Applicable".